Optimizing Scalp Cooling: Structural Follicular Characteristics and Restorative Advances

    Doerthe Schaffrin-Nabe, Anke Josten-Nabe, Adrian Heinze, Andrea Tannapfel, Merle Schaffrin, R. Voigtmann
    Image
    Studysummary This study found that scalp cooling resulted in visible hair retention in 53% of breast cancer patients undergoing Epirubicin/Cyclophosphamide and Paclitaxel treatment, with factors like hair bulb diameter, shaft diameter, and anagen rate significantly predicting outcomes.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    The study investigates the effectiveness of scalp cooling in preventing chemotherapy-induced alopecia among 81 patients, primarily women with breast carcinoma. Scalp cooling prevented visible hair loss in 53% of patients, with hair preservation linked to factors such as hair shaft surface integrity and general health conditions. Damage to the hair shaft surface, particularly post-treatment, significantly affects hair retention. Factors like comorbidities and alopecia-inducing medications were associated with increased hair loss, while higher neutrophil counts correlated with better hair preservation. The study suggests that improving hair shaft structure and managing health conditions could enhance the efficacy of scalp cooling. Additionally, strategies such as real-time shaft monitoring, restorative interventions, antioxidant therapies, and cell cycle arrest agents like palbociclib are proposed to improve outcomes, though further clinical validation is necessary.
    Discuss this study in the Community →

    Research cited in this study

    25 / 25 results